Hamidi, M.; Eriz, A.; Mitxelena, J.; Fernandez-Ares, L.; Aurrekoetxea, I.; Aspichueta, P.; Iglesias-Ara, A.; Zubiaga, A.M.
Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity. Cancers 2022, 14, 4952.
https://doi.org/10.3390/cancers14194952
AMA Style
Hamidi M, Eriz A, Mitxelena J, Fernandez-Ares L, Aurrekoetxea I, Aspichueta P, Iglesias-Ara A, Zubiaga AM.
Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity. Cancers. 2022; 14(19):4952.
https://doi.org/10.3390/cancers14194952
Chicago/Turabian Style
Hamidi, Mohaddase, Ainhoa Eriz, Jone Mitxelena, Larraitz Fernandez-Ares, Igor Aurrekoetxea, Patricia Aspichueta, Ainhoa Iglesias-Ara, and Ana M. Zubiaga.
2022. "Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity" Cancers 14, no. 19: 4952.
https://doi.org/10.3390/cancers14194952
APA Style
Hamidi, M., Eriz, A., Mitxelena, J., Fernandez-Ares, L., Aurrekoetxea, I., Aspichueta, P., Iglesias-Ara, A., & Zubiaga, A. M.
(2022). Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity. Cancers, 14(19), 4952.
https://doi.org/10.3390/cancers14194952